Ypsomed: Press Releases
mylife™ OmniPod® Now Available in France and the Netherlands
mylife™ Diabetescare, Ypsomed's business-to-consumer brand has launched the first insulin patch pump in France and the Netherlands. The launch on the Swiss market will follow at the end...
Ypsomed Invests in the Diabetes Care Business and Wins New Pharmaceutical Customers
In the first half year of the new 2010 - 2011 financial year, Ypsomed has reached significant milestones and achieved important successes on the market. Just six months after announcing...
Ypsomed Launches New Reusable ServoPen in China
Ypsomed launches its newly developed reusable ServoPen® insulin pen for the first time in China together with its long-time customer Tonghua Dongbao Pharmaceutical, a leading pharmaceutical...
Ypsomed Expands Sales of mylife Pen Needles in Latin America, the Middle East and North Africa
The geographical sales expansion in new markets for the patented click-on pen needles produced in Switzerland by Ypsomed is a strategically important objective. With the conclusion of...
mylife OmniPod from Ypsomed: the First Insulin Patch Pump Now Available in Germany and the UK
Ypsomed is launching the first insulin patch pump in Germany and the UK. The mylife™ OmniPod® is a continuous, tubing-free insulin infusion system. It offers people with diabetes who are...
New mylife Diabetescare Website Now Online
As of June 2010, the new mylife™ Diabetescare website is available at www.mylife-diabetescare.com. Ypsomed is taking a new approach in addressing its customers. The web portal offers...
Ypsomed Streamlines Executive Management and Expands European Sales Team
In response to Ypsomed's increased strategic focus as a diabetes specialist company, Ypsomed is streamlining its executive management board in Switzerland and at the same time expanding...
New Blood Glucose Monitoring System from Ypsomed
With its new blood glucose monitoring system Pura™, Ypsomed sets a new standard in blood glucose monitoring. The highly precise blood glucose monitoring device is simple and convenient...
Ypsomed Launches the Ypsopen® in Poland
Ypsomed is to launch its own reusable Ypsopen® pen system in Poland for the administration of insulin. Starting in the spring of 2009, the Ypsopen will be distributed in Poland under the...
New Products Launched, Coupled with Ypsomed's Continued Success
During the 2007/08 business year, Ypsomed was able to conclude two similarly important licensing agreements and, for the first time, achieved CHF 2.3 million in licensing revenues. In May 2007,...
Ypsomed Back on Track for Success
Ypsomed has achieved a great deal and looks back on a successful 2007/08 business year: Total revenues of the Ypsomed group grew by 3.6% to CHF 287.5 million (previous year CHF 277.5...
Ypsomed Launches New DiaExpert Brand Following Successful Integration of Florian Müller
DiaExpert, a subsidiary of the Ypsomed Group, has successfully completed the integration of the Florian Müller Group, a specialist diabetes service provider Ypsomed acquired in July 2007. With...
Ypsomed Annual Results 2006/07 - Return to Profitability
In business year 2006/07 the Ypsomed Group posted consolidated sales of CHF 277.5 million (-10.7% prior year), returning to profitability as announced in the second half of the year...
Ypsomed Concludes License Agreement on Own Auto-injector Patents with Major Pharmaceutical Company
Ypsomed is pleased to announce that it has granted to a major, globally acting pharmaceutical company a non exclusive license to use certain patents, which protect inventions of Ypsomed in...
Ypsomed and Adval Tech Agree a Strategic Cooperation in Moldmaking
Ypsomed AG, Burgdorf and Adval Tech Holding Ltd, Niederwangen, have signed an agreement on a strategic cooperation in moldmaking. The goal of this agreement is to combine the respective ...
Ypsomed's OptiClik® pen production back on track
Burgdorf, 4th July 2006, 7:30 a.m. – Ypsomed has resumed production of the dialling unit for the OptiClik® pen system as planned following an intensive optimisation phase. Matthew Robin, CEO...
Ypsomed acquires additional production facilities in Solothurn
Ypsomed acquires the whole of Ziegelmattareal in Solothurn from Ascom Burgdorf, 27 June 2006, 7:30 am – Ypsomed has substantially increased its production capacity over the last 24 months ...
Ypsomed reduces sales and profit forecasts and appoints new CEO
Burgdorf, 14th September 2006, 7:30 a.m. – Ypsomed today has to issue an ad-hoc information due to lower than expected orders for insulin pen systems. Therefore sales and profitability for...
Twitter